Auburn University
82
15
20
43
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
6.1%
5 terminated/withdrawn out of 82 trials
89.6%
+3.1% vs industry average
0%
0 trials in Phase 3/4
12%
5 of 43 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (82)
Cannabis and Processing Emotions Study
Role: lead
Forge AHEAD: Feasibility of Yoga to Improve Cognitive Function
Role: lead
Using TMS to Understand Neural Processes of Social Motivation
Role: lead
Multimodal Immune and Neuroendocrine Assessment in Drinkers
Role: lead
Testing the Effects of RISE on Eating Pathology
Role: lead
A Combined Neurofeedback-TMS Intervention for Alcohol Use Disorder
Role: lead
Influence of TMS on Attention Modulation
Role: lead
Targeting Minority Stressors to Improve Eating Disorder Symptoms in Sexual Minority Individuals With Eating Disorders
Role: lead
Pilot of Reconnecting to Internal Sensations and Experiences in Undergraduates
Role: lead
Mitochondria Oxidative Stress and Vascular Health Study
Role: lead
Digital Intervention for Physical Activity
Role: lead
Cannabinoids and Biological Reactivity to Stress
Role: collaborator
Safety of Co-Administered CHI-554 and Alcohol
Role: lead
Optimizing Dimensions of Reinforcement
Role: lead
Preventing Relapse of Problem Behavior Through Behavioral Economics: A Translational Analysis
Role: collaborator
Evaluating Body Acceptance Programs for Young Men
Role: lead
Effect of Emotion Mindsets on Emotion Processing
Role: collaborator
Double Crossover Casein Type Tolerance Trial
Role: lead
Sleep and Vascular Health Study
Role: lead
Potassium, Hydration, Cardiovascular, and Kidney Study (PHACKs)
Role: lead